2200 Powell Street
Suite 310
Emeryville, CA 94608
United States
510 204 7200
https://www.xoma.com
Secteur(s):
Secteur d’activité:
Employés à temps plein: 13
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Owen P. Hughes Jr. | CEO & Director | 193,75k | S.O. | 1975 |
Mr. Thomas M. Burns | Senior VP of Finance & CFO | 759,24k | S.O. | 1974 |
Mr. Brad Sitko | Chief Investment Officer | 867,08k | S.O. | 1981 |
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
L’ISS Governance QualityScore de XOMA Corporation en date du 1 avril 2024 est 4. Les scores principaux sont Audit : 7; Société : 3; Droits des actionnaires : 2; Compensation : 7.